Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020.
neoplasms
population attributable fraction
prevention
risk factor
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 11 2023
15 11 2023
Historique:
revised:
05
06
2023
received:
14
11
2022
accepted:
12
06
2023
medline:
19
9
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
In the current study, we aimed to calculate the fraction of cancer attributable to modifiable risk factors in Iran in 2020. Population attributable fractions (PAFs) were calculated for established cancer risk factors using three data sources: the national cancer incidence reports, relative risks extracted from global and national meta-analyses, and exposure prevalence from national/subnational population-based surveys. In addition to overall cancers, the PAFs were estimated separately for each cancer site among men and women. Overall, 32.6% of cancers in 2020 in Iran were attributable to known risk factors. The PAF in men (40.2%) was twice as high as in women (21.1%). Cigarette smoking (15.4%), being overweight (5.0%), opium use (3.9%) and H. pylori infection (3.8%) were the leading causes of cancers. For men, the highest PAFs belonged to cigarette smoking (26.3%), opium use (6.8%) and being overweight (3.1%), while for women, the highest PAFs belonged to being overweight (7.2%), H. pylori infection (2.7%) and cigarette smoking (2.7%). Among Iranian men and women, the PAFs of waterpipe smoking were 2% and 0.9%, respectively. A third of incident cancers in Iran are due to modifiable exposures, mainly cigarette smoking, being overweight, and H. pylori infection. Opium consumption and waterpipe smoking collectively accounted for 8.8% of cancer occurrence in men and 1.3% in women in Iran. These emerging risk factors should be taken into consideration in future PAF studies.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1758-1765Informations de copyright
© 2023 UICC.
Références
WHO. Cancer Control: Knowledge into Action: WHO Guide for Effective Programmes: Module 3: Early Detection. Geneva: World Health Organization Copyright World Health Organization 2007; 2007.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol. 2003;4(1):45-55.
Parkin DM, Boyd L, Walker L. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(S2):S77-S81.
Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99(5):325-332.
Hirayama T. Lifestyle and cancer: from epidemiological evidence to public behavior change to mortality reduction of target cancers. J Natl Cancer Inst Monogr. 1992;12:65-74.
Charafeddine MA, Olson SH, Mukherji D, Temraz SN, Abou-Alfa GK, Shamseddine AI. Proportion of cancer in a middle eastern country attributable to established risk factors. BMC Cancer. 2017;17(1):337.
Cancer Today. Estimated number of new cases in 2020, worldwide: International Agency for Research on Cancer 2022. https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=0&include_nmsc_other=1
Roshandel G, Ferlay J, Ghanbari-Motlagh A, et al. Cancer in Iran 2008 to 2025: recent incidence trends and short-term predictions of the future burden. Int J Cancer. 2021;149(3):594-605.
Schmidhuber J, Shetty P. The nutrition transition to 2030. Why developing countries are likely to bear the major burden. Acta Agric Scand Sect C. 2005;2(3-4):150-166.
Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and waterpipe use in Iran: geographical distribution and time trends among the adult population; A pooled analysis of national STEPS surveys, 2006-2009. Arch Iran Med. 2017;20(5):295-301.
Mannucci PM, Franchini M. Health effects of ambient air pollution in developing countries. Int J Environ Res Public Health. 2017;14(9):1048.
Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3-21.
e Silva GA, De Moura L, Curado MP, et al. The fraction of cancer attributable to ways of life, infections, occupation, and environmental agents in Brazil in 2020. PLoS One. 2016;11(2):e0148761.
Kulhánová I, Znaor A, Shield KD, et al. Proportion of cancers attributable to major lifestyle and environmental risk factors in the eastern Mediterranean region. Int J Cancer. 2020;146(3):646-656.
Tran KB, Lang JJ, Compton K, et al. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563-591.
Cancer IAfRo. Agents classified by the IARC monographs, vol. 1-100. http://monographsiarcfr/ENG/Classification/ClassificationsAlphaOrder.pdf. 2010.
Diet, activity and cancer: cancer risk factors World Cancer Research Fund International. 2023 https://www.wcrf.org/diet-activity-and-cancer/risk-factors/
Djalalinia S, Modirian M, Sheidaei A, et al. Protocol design for large-scale cross-sectional studies of surveillance of risk factors of non-communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9):608-616.
Khodakarami N, Clifford GM, Yavari P, et al. Human papillomavirus infection in women with and without cervical cancer in Tehran. Iran Int J Cancer. 2012;131(2):E156-E161.
Poustchi H, Eghtesad S, Kamangar F, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647-655.
Hadji M, Rashidian H, Marzban M, et al. The Iranian study of opium and cancer (IROPICAN): rationale, design, and initial findings. Arch Iran Med. 2021;24(3):167-176.
General population and housing censuses 2016 Statistical Center of Iran. 2022 https://www.amar.org.ir/english/Population-and-Housing-Censuses
Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31-54.
Mamtani R, Cheema S, Sheikh J, Al Mulla A, Lowenfels A, Maisonneuve P. Cancer risk in waterpipe smokers: a meta-analysis. Int J Public Health. 2017;62(1):73-83.
Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531-941.
Greenland S. Interval estimation by simulation as an alternative to and extension of confidence intervals. Int J Epidemiol. 2004;33(6):1389-1397.
Inoue M, Sawada N, Matsuda T, et al. Attributable causes of cancer in Japan in 2005: systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol. 2012;23(5):1362-1369.
Whiteman DC, Webb PM, Green AC, et al. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N Z J Public Health. 2015;39(5):477-484.
Tybjerg AJ, Friis S, Brown K, Nilbert MC, Morch L, Køster B. Updated fraction of cancer attributable to lifestyle and environmental factors in Denmark in 2018. Sci Rep. 2022;12(1):1-11.
Nemati S, Rafei A, Mehrtash H, Freedman ND, Fotouhi A, Zendehdel K. Socioeconomic inequality in prevalence of cigarette and waterpipe smoking among Iranian adults: a blinder-Oaxaca decomposition analysis. Basic Clin Cancer Res. 2019;11(4):156-165.
Age-standardized estimates of current tobacco use, tobacco smoking and cigarette smoking data by country World Health Organization: Global Health Observatory data repository (Eastern Mediterranean Region). 2023 https://apps.who.int/gho/data/node.main-emro.TOBAGESTDCURR?lang=en
Boffetta P, Tubiana M, Hill C, et al. The causes of cancer in France. Ann Oncol. 2008;20(3):550-555.
Maziak W, Osibogun O, Asfar T. Waterpipe smoking: the pressing need for risk communication. Expert Rev Respir Med. 2019;13(11):1109-1119.
Brenner DR. Cancer incidence due to excess body weight and leisure-time physical inactivity in Canada: implications for prevention. Prev Med. 2014;66:131-139.
Esmaillzadeh A, Azadbakht L. Major dietary patterns in relation to general obesity and central adiposity among Iranian women. J Nutr. 2008;138(2):358-363.
Kafeshani O, Sarrafzadegan N, Nouri F, Mohammadifard N. Major dietary patterns in Iranian adolescents: Isfahan healthy heart program, Iran. ARYA Atheroscler. 2015;11(Suppl 1):61-68.
Organization WH. Global Health Observatory. Overweight and obesity. Database. Geneva, Switzerland: WHO. 2013 http://www.who.int/gho/ncd/risk_factors/overweight/en/
Ekpenyong C, Akpan E. Contextual trend in preventing obesity epidemic in developing countries: role of the key players. Eur J Prev Med. 2013;1(1):20-31.
Iran Census 2016 Statistics Center of Iran; 2022. https://www.amar.org.ir/english.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378-397.
Aune D, Navarro Rosenblatt D, Chan D, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol. 2015;26(8):1635-1648.
Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009;12(6):576-583.
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180-e190.
Khorasanizadeh F, Hassanloo J, Khaksar N, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women: analyses of national data and systematic review of the literature. Gynecol Oncol. 2013;128(2):277-281.
Sheikh M, Shakeri R, Poustchi H, et al. Opium use and subsequent incidence of cancer: results from the Golestan cohort study. Lancet Glob Health. 2020;8(5):e649-e660.
Warnakulasuriya S, Cronin-Fenton D, Jinot J, et al. Carcinogenicity of opium consumption. Lancet Oncol. 2020;21(11):1407.
Christensen JB. Drugs, Deviancy and Democracy in Iran: The Interaction of State and Civil Society. London: Palgrave Macmillan; 2011.
Zarghami M. Iranian common attitude toward opium consumption. Iran J Psych Behav Sci. 2015;9(2):e2074.
Mohebbi E, Hadji M, Rashidian H, et al. Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 2021;148(5):1066-1076.
Mohammadi N, Alimohammadian M, Feizesani A, et al. The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: an analysis of 49,946 cases in the Golestan cohort study, Iran. PLoS One. 2021;16(1):e0246004.
Crime UNOoDa. World drug report 2021, Prevalene of drug use United Nations publication. 2021.
Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: an emerging risk factor for cancer? Lancet Oncol. 2014;15(2):e69-e77.
Sheikh M, Kamangar F, Malekzadeh R. Fifty years of research and one conclusion: opium causes cancer. Arch Iran Med. 2020;23(11):757-760.
Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci. 2005;5(2):380-382.
Nemati S, Naji P, Abdi S, et al. National and regional fraction of cancer incidence and death attributable to current tobacco and waterpipe smoking in the eastern Mediterranean countries in 2020. Nicotine Tob Res. 2023;25(1):12-18.